Japan’s SoftBank Group Corp. is in early talks to invest close to $100 million in online medicine startup PharmEasy, three people aware of the matter said. PharmEasy is seeking a valuation of about $400 million in the latest round of funding, more than double what it was valued in the previous fundraising, the people cited above said on condition of anonymity.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in